These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1357748)

  • 21. The role of glutamate in neurotransmission and in neurologic disease.
    Greenamyre JT
    Arch Neurol; 1986 Oct; 43(10):1058-63. PubMed ID: 2428340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate-gated ion channels in the brain. Genetic mechanism for generating molecular and functional diversity.
    Sommer B; Monyer H; Wisden W; Verdoorn TA; Burnashev N; Sprengel R; Sakmann B; Seeburg PH
    Arzneimittelforschung; 1992 Feb; 42(2A):209-10. PubMed ID: 1375026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamate neurotoxicity and diseases of the nervous system.
    Choi DW
    Neuron; 1988 Oct; 1(8):623-34. PubMed ID: 2908446
    [No Abstract]   [Full Text] [Related]  

  • 24. Species-dependent functional properties of non-NMDA receptors expressed in Xenopus laevis oocytes injected with mammalian and avian brain mRNA.
    Bowie D; Smart TG
    Br J Pharmacol; 1994 Mar; 111(3):803-10. PubMed ID: 7517329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamate in the mammalian CNS.
    Sahai S
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(2):121-33. PubMed ID: 1981150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of glutamate-activated channels in primary culture of cortical neurons.
    Vinini S; Bertolino M; Costa E
    P R Health Sci J; 1988 Aug; 7(2):93-5. PubMed ID: 2460894
    [No Abstract]   [Full Text] [Related]  

  • 27. The non-excitatory mechanisms of glutamate induced neurotoxicity.
    Coyle JT; Murphy TH; Puttfarcken PS; Lyons EW; Vornov JJ
    Epilepsy Res; 1991 Oct; 10(1):41-8. PubMed ID: 1686428
    [No Abstract]   [Full Text] [Related]  

  • 28. [Analysis of synaptic transmission in rat hippocampal slices using a modified method of potential fixation].
    Garashchuk OV; Koval'chuk IuN; Kryshtal' OA
    Neirofiziologiia; 1991; 23(6):731-8. PubMed ID: 1686793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
    Bleakman D; Rusin KI; Chard PS; Glaum SR; Miller RJ
    Mol Pharmacol; 1992 Aug; 42(2):192-6. PubMed ID: 1381041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamate receptors and phosphoinositide metabolism: stimulation via quisqualate receptors is inhibited by N-methyl-D-aspartate receptor activation.
    Palmer E; Monaghan DT; Cotman CW
    Brain Res; 1988 Sep; 464(2):161-5. PubMed ID: 2905924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid-glutamate interactions in rat locus coeruleus neurons.
    Oleskevich S; Clements JD; Williams JT
    J Neurophysiol; 1993 Sep; 70(3):931-7. PubMed ID: 7693886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor types mediating the excitatory actions of exogenous L-aspartate and L-glutamate in rat olfactory cortex.
    Surtees L; Collins GG
    Brain Res; 1985 May; 334(2):287-95. PubMed ID: 2859914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology of excitatory amino acid receptors].
    Shinozaki H
    Yakubutsu Seishin Kodo; 1992 Apr; 12(2):55-65. PubMed ID: 1359719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of excitotoxins in developmental neuropathology.
    Olney JW
    APMIS Suppl; 1993; 40():103-12. PubMed ID: 8311990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
    Pittaluga A; Raiteri M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity.
    Cotman CW; Monaghan DT; Ganong AH
    Annu Rev Neurosci; 1988; 11():61-80. PubMed ID: 2452598
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.
    Konradi C; Heckers S
    Pharmacol Ther; 2003 Feb; 97(2):153-79. PubMed ID: 12559388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-Glutamate: its interactions with spinal neurons.
    Puil E
    Brain Res; 1981 Dec; 228(3):229-322. PubMed ID: 6118198
    [No Abstract]   [Full Text] [Related]  

  • 40. Introduction to the excitatory amino acid system.
    Fisher RS
    Epilepsy Res; 1991 Oct; 10(1):3-8. PubMed ID: 1686427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.